The Precision of Swiss Technology. Nestled among the spectacular beauty of the Swiss city of Lausanne, is the prestigious University Hospital. Originally established in the thirteenth century, today, the University Hospital of Lausanne is a leading international research facility in medicine, and the birthplace of modern Swiss innovation.
The Quest to Heal. Through years of intensive research on scarless wound healing, physicians discovered the unique ability of fetal skin to heal without scarring. Inspired by this phenomena, medical researchers at the University Hospital of Lausanne created a biotechnology process to obtain the rich proteins responsible for scarless wound healing from cultured fibroblasts.
Unparalleled Innovation. A dedicated cell bank was established for developing new skin treatments using a single donation of fetal tissue under the strict legal and ethical laws of Switzerland. Originally established for wound healing and burn treatments, the same cell bank provides a lasting supply of fibroblasts for producing PSP, a proprietary skincare ingredient exclusive to NEOCUTIS.
Latisse An FDA-approved prescription treatment for hypotrichosis used to increase eyelash growth, making them longer, thicker and darker. Latisse is a once-a-day treatment applied to the base of the upper eyelashes. Results are seen gradually, usually starting at 4 weeks with full results after 16 weeks of continued use.
The active ingredient in Latisse is bimatoprost, which is also the active ingredient in the glaucoma drug Lumigan. Research suggests that the growth of eyelashes occurs by increasing the number of eyelash hairs during the eyelash growth phase. Lashes can grow longer, thicker, and darker because bimatoprost can also prolong the growth phase.